Year: 2023

SINGAPORE, Nov. 13, 2023 (GLOBE NEWSWIRE) — SAI.TECH Global Corporation (“SAI.TECH” or “SAI” or the “Company”, NASDAQ: SAI, SAITW), today reported unaudited financial results for the six months ended June 30, 2023. Financial Highlights for the Six Months Ended June 30, 2023Total revenues for the six months ended June 30, 2023, were US$ 3.0 million, having decreased 44% compared to the six months ended June 30, 2022.Gross profits for the six months ended June 30, 2023, was US $0.2 million, having decreased 70% compared to the six months ended June 30, 2022.Net losses for the six months ended June 30, 2023, was US$3.7 million compared to net losses of US$2.7 million for the six months ended June 30, 2022.Mr. Arthur Lee, Chairman and Chief Executive Officer of the Company, stated that, “The negative impact caused by tightened...

GRAPEVINE, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) — Southland Holdings, Inc. (NYSE American: SLND and SLND WS) (“Southland”), a leading provider of specialized infrastructure construction services, today announced financial results for quarter ended September 30, 2023.Revenue of $312 million for the quarter ended September 30, 2023, down 6.8% from $335 million for the quarter ended September 30, 2022. Gross profit of $30 million for the quarter ended September 30, 2023, compared to $62 million for the quarter ended September 30, 2022. Net income attributable to stockholders of $4 million, or $0.08 per diluted share for the quarter ended September 30, 2023, compared to a net income attributable to stockholders of $35 million for the quarter ended September 30, 2022. EBITDA of $22 million for the quarter ended September 30, 2023,...

BELGRADE, Mont., Nov. 13, 2023 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today reported record results for the third quarter ended September 30, 2023 and an update on guidance including the establishment of initial 2024 Revenue and Adjusted EBITDA estimates. Highlights:Achieved record quarterly revenue, net income, and Adjusted EBITDA of $53.6 million, $17.5 million and $38.7 million, respectively, in the third quarter of 2023 Bridger’s Super Scooper fleet experienced its highest level of utilization ever during the third quarter despite a shorter-than-average North American wildfire season In the process of acquiring four Spanish Super Scoopers won at auction by the Spanish government...

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the third quarter of 2023. “This quarter, we continued to drive adoption of our instruments and kits, make progress against important collaborations, advance our mRNA strategy, and strengthen both our Board of Directors and Management Team,” said Todd R. Nelson, PhD, CEO, and founder of Telesis Bio. Highlights Strengthened board of directors and management team:Appointed Greg Herrema, Senior Advisor to Novalis LifeSciences to the Telesis Bio board of directors in October 2023. Mr. Herrema’s distinguished career has included almost 20 years at Thermo Fisher Scientific in multiple division and group president roles. Before that, Mr. Herrema was with General...

U.S. FDA granted Investigational Device Exemption (“IDE”) approval to initiate the BACKBEAT pivotal study evaluating AVIM therapy (BackBeat CNT) in hypertensive pacemaker patients BACKBEAT pivotal study on track to start enrollment before the end of 2023, with a mid-2025 target for completion of enrollment Expected operating cash runway sufficient into 2H 2026, beyond anticipated BACKBEAT top-line results readout, based on internal forecast FDA also granted conditional IDE approval for pivotal study of Virtue® SAB in coronary in-stent restenosis (“ISR”) patients; Virtue ISR-US study initiation targeted for 2024, pending Terumo partnership restructuringNEW HOPE, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact...

Gevo to Host Conference Call Today at 4:30 p.m. ET ENGLEWOOD, Colo., Nov. 13, 2023 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the third quarter of 2023 and recent corporate highlights. Recent Corporate HighlightsRenewable Natural Gas (“RNG”): The previously announced capacity expansion from 355,000 MMBtu to 400,000 MMBtu was completed during the third quarter of 2023.Verity: This quarter, we entered into agreements with an ethanol producer customer in the US Southwest. This brings our growing total ethanol producer customer base to three customers, and total planned volume of ethanol tracked by Verity to over 300M gallons per year, or approximately 2% of the US ethanol market, since March 2023. Our agreements with customers will allow them...

 — Closed on $3.2 Million Financing — Delivered $29.3 Million in nine-month revenue     — Won 2023 BeautyMatter NEXT Award — Named as finalist for 22nd annual Chicago Innovation Awards and 2024 Cosmetics & Toiletries Allē Awards  ROMEOVILLE, Ill., Nov. 13, 2023 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced financial results for the third quarter ended September 30, 2023.   Jess Jankowski, President and Chief Executive Officer, commented: “We’ve had our ups and downs in the third quarter, but critically, we’ve positioned ourselves for success as we look to a strong year for...

Advances rollout of POCare Platform and POCare Therapies GERMANTOWN, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for the third quarter ended September 30, 2023. Vered Caplan, CEO of Orgenesis, said, “We continue to advance the commercial launch of our POCare Platform through Octomera, building out a decentralized network and infrastructure to deliver these advanced therapeutic services that are critically needed by the medical community. At the same time, we are focused on growing our POCare Network of hospitals and healthcare providers across the U.S., Europe, the Middle East and other regions, where advanced cell and gene therapies can be rapidly...

Selected Unaudited Financial Highlights for Q3 FY 2023 Self-mined Bitcoin revenue and Bitcoin mined increased 41% and 35% Q/Q, respectively, to $6.9 Million and 246 BTC Total Quarterly Revenue increased to $11.3 Million SG&A Expenses Decreased 42% Q/Q PITTSBURGH, Nov. 13, 2023 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson”, Company), a digital infrastructure company, today announced its unaudited financial results and highlights for the third quarter ending September 30, 2023. Rahul Mewawalla, CEO and President of Mawson, said, “We are delighted to deliver a second successful consecutive quarter of significant double-digit sequential revenue growth for our self-mining business as we continued to execute our new operating excellence model combined with our business, technology, and financial optimization...

Strategic Focus On Cross-Platform Offerings and Brand Solutions Driving Improved Revenue Mix and 400bp Expansion in Gross Margins Year-over-Year as Company Progresses Toward Profitability LOS ANGELES, Nov. 13, 2023 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming media and entertainment company, today announced financial results for the three and nine months ended September 30, 2023 (“Q3 2023”). Q3 2023 Financial HighlightsRevenue of $45.6 million, a decrease of 10% compared to Q3 2022 Gross profit of $16.7 million, an increase of 1% compared to Q3 2022, with gross profit margins expanding 400 basis points year-over-year to 36.7% Operating expenses of $25.0 million, a decrease of 6% compared to Q3 2022 Ended the quarter with $2.8 million of cash, along with...